Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
1.
Hum Resour Health ; 17(1): 40, 2019 05 31.
Artigo em Inglês | MEDLINE | ID: mdl-31151400

RESUMO

BACKGROUND: Despite increasing popularity among health organizations of pay for performance (P4P) for the provision of comprehensive care for chronic non-communicable diseases, evidence of its effectiveness in improving health system outcomes is weak. An important void in the evidence base is whether there are gendered differences in P4P uptake and in related outcomes amenable to healthcare improvement. This study assesses the gender-specific effects of P4P among family physicians on diabetes healthcare costs in a context of universal health coverage. METHODS: We use population-based linked longitudinal administrative datasets on chronic disease cases, physician billings, hospital discharge abstracts, and physician and resident registries in the province of New Brunswick, Canada. We estimate the effects of introduction of a P4P scheme on excess public healthcare costs among cohorts of adult diabetes patients using propensity score-adjusted difference-in-differences regressions stratified by physician's gender. RESULTS: We observed greater male physician uptake of incentive payments, seemingly exacerbating gender gaps in professional remuneration. Regression results indicated P4P did not lead to improved outcomes in terms of preventing hospitalization costs among patients, only measurable increases in compensation for both the male and female physician workforce. CONCLUSIONS: While P4P was not attributed in this study to reduced hospital burden and enhanced sustainability of healthcare financing, incentive payments were found to be related to earning gaps by physician's gender. Decision-makers should consider that benefits of P4P be monitored not only for patient metrics but also for provider metrics in terms of gender equality especially given feminization of primary care medical workforces.


Assuntos
Doença Crônica/terapia , Médicos de Família/economia , Reembolso de Incentivo/economia , Cobertura Universal do Seguro de Saúde/organização & administração , Adulto , Doença Crônica/economia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Novo Brunswick , Médicos de Família/organização & administração , Reembolso de Incentivo/organização & administração , Fatores Sexuais , Cobertura Universal do Seguro de Saúde/economia
2.
Can J Diabetes ; 43(5): 354-360.e1, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30679059

RESUMO

OBJECTIVES: In New Brunswick, Canada, 13.6% of the population 35 years of age and older is living with type 1 or type 2 diabetes mellitus. To address public health and clinical challenges, pay-for-performance (P4P) for family physicians was introduced in 2010 to enable comprehensive diabetes management. This study assesses the impacts of the P4P scheme on excess health-care costs. METHODS: We used a quasiexperimental study design drawing on linked population-based administrative data sets of physician billings, hospital discharge abstracts and provider and resident registrations. Prospective cohorts of patients with diabetes were identified through a validated algorithm tracing individuals' interactions with the health-care system. We applied propensity-score difference-in-differences estimation for the effects of P4P on preventable diabetes-related hospitalization costs according to patients' exposures to physicians' uptake of the incentive. RESULTS: Coverage of incentivized care peaked at less than half (44%) of adults with diabetes, who tended to be younger and less often presenting comorbid conditions compared to those whose providers did not claim incentives. The introduction of P4P was attributed to significantly lower diabetes hospitalization costs among newly diagnosed patients (-0.083; p<0.01) and improved compensation for physicians. No cost avoidance was established among medium-term and longer-term patients or for hospitalizations for conditions concordant with diabetes. CONCLUSIONS: The effects of New Brunswick's P4P for diabetes care are mixed. Results reflect the deficient evidence base on the effects of P4P on patient-oriented and policymaker-important health outcomes. The high risk for multiple morbidities among patients with diabetes and the heterogeneity of physician responses to performance incentives may be hindering the effectiveness of P4P in improving diabetes outcomes.


Assuntos
Atenção à Saúde/economia , Diabetes Mellitus Tipo 1/economia , Diabetes Mellitus Tipo 2/economia , Hipoglicemiantes/economia , Programas de Assistência Gerenciada/economia , Médicos de Atenção Primária/normas , Reembolso de Incentivo/estatística & dados numéricos , Adulto , Idoso , Atenção à Saúde/estatística & dados numéricos , Diabetes Mellitus Tipo 1/tratamento farmacológico , Diabetes Mellitus Tipo 1/epidemiologia , Diabetes Mellitus Tipo 2/tratamento farmacológico , Diabetes Mellitus Tipo 2/epidemiologia , Feminino , Seguimentos , Custos de Cuidados de Saúde , Hospitalização , Humanos , Hipoglicemiantes/uso terapêutico , Masculino , Programas de Assistência Gerenciada/organização & administração , Programas de Assistência Gerenciada/normas , Pessoa de Meia-Idade , Novo Brunswick/epidemiologia , Ensaios Clínicos Controlados não Aleatórios como Assunto , Médicos de Atenção Primária/economia , Médicos de Atenção Primária/organização & administração , Prognóstico , Estudos Prospectivos
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa